Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene

被引:71
作者
Unoki, M
Furuta, S
Onouchi, Y
Watanabe, O
Doi, S
Fujiwara, H
Miyatake, A
Fujita, K
Tamari, M
Nakamura, Y
机构
[1] Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, Tokyo 1088639, Japan
[2] Osaka Prefectural Habikino Hosp, Osaka, Japan
[3] Miyatake Asthma Clin, Osaka, Japan
[4] Univ Shiga, Coll Nursing, Shiga, Japan
基金
日本学术振兴会;
关键词
D O I
10.1007/s004390000267
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although intensive studies have attempted to elucidate the genetic background of bronchial asthma (BA), one of the most common of the chronic inflammatory diseases in human populations, genetic factors associated with its pathogenesis are still not well understood. We surveyed 29 possible candidate genes for this disease for single nucleotide polymorphisms (SNPs), the most frequent type of genetic variation, in genomic DNAs from Japanese BA patients. We identified 33 SNPs, only four of which had been reported previously, among 14 of those genes. We also performed association studies using 585 BA patients and 343 normal controls for these SNPs. Of the 33 SNPs tested, 32 revealed no positive association with BA, but a T924C polymorphism in the thromboxane A2 receptor gene showed significant association (chi 2= 4.71, P=0.030), especially with respect to adult patients (chi 2=6.20, P=0.013). Our results suggest that variants of the TBXA2R gene or some nearby gene(s) may play an important role in the pathogenesis of adult BA.
引用
收藏
页码:440 / 446
页数:7
相关论文
共 19 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   Characterization of single-nucleotide polymorphisms in coding regions of human genes [J].
Cargill, M ;
Altshuler, D ;
Ireland, J ;
Sklar, P ;
Ardlie, K ;
Patil, N ;
Lane, CR ;
Lim, EP ;
Kalyanaraman, N ;
Nemesh, J ;
Ziaugra, L ;
Friedland, L ;
Rolfe, A ;
Warrington, J ;
Lipshutz, R ;
Daley, GQ ;
Lander, ES .
NATURE GENETICS, 1999, 22 (03) :231-238
[3]  
Deichmann KA, 1999, CLIN EXP ALLERGY, V29, P794
[4]   Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment [J].
Drazen, JM ;
Yandava, CN ;
Dubé, L ;
Szczerback, N ;
Hippensteel, R ;
Pillari, A ;
Israel, E ;
Schork, N ;
Silverman, ES ;
Katz, DA ;
Drajesk, J .
NATURE GENETICS, 1999, 22 (02) :168-170
[5]   Treatment of asthma with drugs modifying the leukotriene pathway [J].
Drazen, JM ;
Israel, E ;
O'Byrne, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (03) :197-206
[7]  
Hijazi Z, 1998, CLIN GENET, V53, P149
[8]   ARG(60) TO LEU MUTATION OF THE HUMAN THROMBOXANE A(2) RECEPTOR IN A DOMINANTLY INHERITED BLEEDING DISORDER [J].
HIRATA, T ;
KAKIZUKA, A ;
USHIKUBI, F ;
FUSE, I ;
OKUMA, M ;
NARUMIYA, S .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (04) :1662-1667
[9]   Association of glutamine 27 polymorphism of β2 adrenoceptor with reported childhood asthma:: population based study [J].
Hopes, E ;
McDougall, C ;
Christie, G ;
Dewar, J ;
Wheatley, A ;
Hall, IP ;
Helms, PJ .
BRITISH MEDICAL JOURNAL, 1998, 316 (7132) :664-664
[10]   No association between atonic asthma and a coding variant of FcεR1β in a Japanese population [J].
Ishizawa, M ;
Shibasaki, M ;
Yokouchi, Y ;
Noguchi, E ;
Arinami, T ;
Yamakawa-Kobayashi, K ;
Matsui, A ;
Hamaguchi, H .
JOURNAL OF HUMAN GENETICS, 1999, 44 (05) :308-311